Denali Therapeutics
DNLI
DNLI
216 hedge funds and large institutions have $3.68B invested in Denali Therapeutics in 2024 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 79 increasing their positions, 58 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 203 → 216 (+13)
1.38% more ownership
Funds ownership: 86.88% → 88.26% (+1.4%)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
216
Holding in Top 10
1
Calls
$2.01M
Puts
$1.17M
Top Buyers
| 1 | +$221M | |
| 2 | +$42.3M | |
| 3 | +$30M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$26.3M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$22.8M |
Top Sellers
| 1 | -$97.9M | |
| 2 | -$21M | |
| 3 | -$16.3M | |
| 4 |
YCM
Yiheng Capital Management
San Francisco,
California
|
-$16M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$13.2M |